Man Group plc Takes Position in LENSAR, Inc. $LNSR

Man Group plc acquired a new position in LENSAR, Inc. (NASDAQ:LNSR) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 77,962 shares of the company’s stock, valued at approximately $445,000. Man Group plc owned 0.63% of LENSAR as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in the business. BNP Paribas Financial Markets grew its holdings in LENSAR by 129.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,008 shares of the company’s stock valued at $25,000 after buying an additional 1,131 shares during the last quarter. Bank of New York Mellon Corp acquired a new position in shares of LENSAR during the second quarter worth approximately $58,000. JPMorgan Chase & Co. lifted its holdings in shares of LENSAR by 584.3% during the second quarter. JPMorgan Chase & Co. now owns 4,674 shares of the company’s stock worth $62,000 after buying an additional 3,991 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of LENSAR in the second quarter valued at approximately $68,000. Finally, Sanctuary Advisors LLC acquired a new stake in shares of LENSAR in the second quarter worth $96,000. Institutional investors and hedge funds own 40.15% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on LNSR. Weiss Ratings lowered shares of LENSAR from a “sell (d+)” rating to a “sell (d)” rating in a research report on Friday, August 21st. Lake Street Capital reissued a “buy” rating and issued a $13.00 price target on shares of LENSAR in a report on Thursday, August 13th. Wall Street Zen upgraded shares of LENSAR from a “hold” rating to a “buy” rating in a research report on Sunday, August 23rd. Finally, BTIG Research boosted their price objective on shares of LENSAR from $9.00 to $10.00 and gave the stock a “buy” rating in a report on Thursday, August 20th. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, LENSAR presently has an average rating of “Hold” and an average price target of $11.50.

LENSAR Trading Up 4.0%

Shares of NASDAQ:LNSR opened at $8.58 on Friday. LENSAR, Inc. has a 1-year low of $4.95 and a 1-year high of $12.94. The firm has a market capitalization of $105.45 million, a PE ratio of -26.00 and a beta of 0.97. The business’s 50 day moving average is $6.70 and its 200-day moving average is $6.97.

LENSAR (NASDAQ:LNSR) last released its quarterly earnings data on Thursday, August 13th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.26. The business had revenue of $16.50 million for the quarter, compared to analysts’ expectations of $14.65 million. LENSAR had a negative return on equity of 529.08% and a net margin of 57.57%.

LENSAR Company Profile

LENSAR, Inc, headquartered in Orlando, Florida, is a medical technology company specializing in advanced laser systems for ophthalmic surgery. Its flagship product, the LENSAR Laser System, combines proprietary three-dimensional imaging with precision-guided femtosecond laser delivery to perform critical steps in cataract procedures, including capsulotomy creation, lens fragmentation and corneal incisions.

Founded in 2005, LENSAR has concentrated its research and development efforts on enhancing surgical accuracy and patient outcomes in cataract treatment.